Sign in

CIK 0001070494 · Large accelerated filer

ACADIA PHARMACEUTICALS INC

Sign in to watch
Ticker
ACAD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
061376651
Phone
858-558-2871
Business address
12830 EL CAMINO REAL, SUITE 400, SAN DIEGO, CA, 92130
  1. 4 Open-market sale EVP, CHIEF FINANCIAL OFFICER sold 7,385 shares at an average $21.55 ($159,136)
  2. 4 Derivatives Options or other derivatives
  3. 3 Insider Initial Statement of Ownership
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Open-market sale EVP, CHIEF LEGAL OFFICER, SEC sold 6,950 shares at $23.38 ($162,491)
  11. 4 Open-market sale EVP, CHIEF FINANCIAL OFFICER sold 10,262 shares at $23.69 ($243,114)
  12. 4 Open-market sale PRINCIPAL ACCOUNTING OFFICER sold 4,084 shares at $23.69 ($96,754)
  13. 4 Open-market sale Director sold 30,000 shares at $22.37 ($670,983)
  14. 4 Open-market sale EVP, CHIEF FINANCIAL OFFICER sold 3,498 shares at $23.65 ($82,728)
  15. 4 Open-market sale Director sold 1,600 shares at $25.98 ($41,560)
  16. 4 Planned sale EVP, CHIEF FINANCIAL OFFICER sold 22,000 shares at $25.18 ($554,024)
  17. 4 Open-market sale Director sold 14,446 shares at $21.78 ($314,634)
  18. 4 Option exercise Director acquired 9,387 shares (option exercise)
  19. 4 Option exercise Director acquired 9,387 shares (option exercise)
  20. 4 Option exercise Director acquired 9,387 shares (option exercise)

Page 2 of 35 · 686 filings